Stephens Investment Management Group LLC Takes $11.39 Million Position in Amprius Technologies, Inc. $AMPX

Key Points

• Stephens Investment Management bought a new stake of 1,082,907 shares in Amprius (NYSE:AMPX) in the third quarter, valued at about $11.39 million and representing roughly 0.87% of the company.
• Significant insider selling: CEO Kang Sun sold 1,000,000 shares (~$10.6M) and CTO Constantin Ionel Stefan sold 198,255 shares (~$2.08M), with insiders offloading 1.798M shares worth $18.74M over the past 90 days.
• Mixed financial/market picture: Amprius beat quarterly estimates (EPS -$0.03 vs. -$0.06; revenue $21.43M vs. $16.45M), but remains unprofitable (negative margins and ROE); market cap is ~$1.44B and analysts have an average rating of "Moderate Buy" with a $14.57 average price target.

Stephens Investment Management Group LLC bought a new stake in Amprius Technologies, Inc. (NYSE:AMPX - Free Report) in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 1,082,907 shares of the company's stock, valued at approximately $11,392,000. Stephens Investment Management Group LLC owned approximately 0.87% of Amprius Technologies as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds also recently bought and sold shares of the company. Vanguard Personalized Indexing Management LLC grew its stake in shares of Amprius Technologies by 17.7% in the 2nd quarter. Vanguard Personalized Indexing Management LLC now owns 19,134 shares of the company's stock worth $81,000 after buying an additional 2,873 shares in the last quarter. Bank of America Corp DE lifted its holdings in shares of Amprius Technologies by 31.1% in the 4th quarter. Bank of America Corp DE now owns 12,890 shares of the company's stock valued at $36,000 after acquiring an additional 3,055 shares during the last quarter. Rhumbline Advisers lifted its holdings in shares of Amprius Technologies by 61.1% in the 1st quarter. Rhumbline Advisers now owns 15,690 shares of the company's stock valued at $42,000 after acquiring an additional 5,951 shares during the last quarter. Geneos Wealth Management Inc. purchased a new position in Amprius Technologies in the third quarter worth about $74,000. Finally, Ameritas Investment Partners Inc. increased its stake in Amprius Technologies by 2,043.2% during the second quarter. Ameritas Investment Partners Inc. now owns 9,516 shares of the company's stock worth $40,000 after acquiring an additional 9,072 shares during the last quarter. Hedge funds and other institutional investors own 5.04% of the company's stock.

Amprius Technologies Stock Up 8.4%

AMPX stock opened at $11.00 on Friday. Amprius Technologies, Inc. has a twelve month low of $1.70 and a twelve month high of $16.03. The firm has a market cap of $1.44 billion, a price-to-earnings ratio of -42.31 and a beta of 3.04. The business's fifty day simple moving average is $10.22 and its two-hundred day simple moving average is $9.62.

Amprius Technologies (NYSE:AMPX - Get Free Report) last posted its quarterly earnings results on Thursday, November 6th. The company reported ($0.03) EPS for the quarter, topping analysts' consensus estimates of ($0.06) by $0.03. The firm had revenue of $21.43 million for the quarter, compared to analysts' expectations of $16.45 million. Amprius Technologies had a negative net margin of 53.16% and a negative return on equity of 38.85%. Research analysts expect that Amprius Technologies, Inc. will post -0.45 EPS for the current year.

Analyst Ratings Changes

Several research firms have recently issued reports on AMPX. Oppenheimer reaffirmed an "outperform" rating and issued a $17.00 price objective on shares of Amprius Technologies in a research note on Tuesday, December 23rd. Northland Securities set a $20.00 price target on Amprius Technologies in a research report on Tuesday, October 7th. Cantor Fitzgerald boosted their price objective on shares of Amprius Technologies from $12.00 to $16.00 and gave the company an "overweight" rating in a research report on Friday, November 7th. Roth Capital set a $14.00 target price on shares of Amprius Technologies and gave the company a "buy" rating in a research note on Wednesday, October 22nd. Finally, Weiss Ratings reaffirmed a "sell (e+)" rating on shares of Amprius Technologies in a research note on Wednesday, October 8th. Seven analysts have rated the stock with a Buy rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average price target of $14.57.

Insider Buying and Selling

In related news, CTO Constantin Ionel Stefan sold 198,255 shares of the stock in a transaction that occurred on Thursday, December 11th. The stock was sold at an average price of $10.51, for a total value of $2,083,660.05. Following the transaction, the chief technology officer owned 748,696 shares of the company's stock, valued at $7,868,794.96. This represents a 20.94% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Kang Sun sold 1,000,000 shares of Amprius Technologies stock in a transaction on Monday, November 17th. The shares were sold at an average price of $10.60, for a total value of $10,600,000.00. Following the sale, the chief executive officer directly owned 1,472,306 shares of the company's stock, valued at approximately $15,606,443.60. This trade represents a 40.45% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders have sold 1,798,201 shares of company stock worth $18,741,241. Corporate insiders own 12.90% of the company's stock.

Amprius Technologies Profile

Amprius Technologies, Inc NYSE: AMPX is a U.S.-based developer of high-energy-density lithium-ion batteries that leverage silicon anode technology to deliver performance levels beyond conventional graphite-based cells. The company's batteries are designed to offer industry-leading gravimetric energy density, enabling longer run times and reduced weight for portable power applications. Amprius blends advanced materials science and scalable manufacturing processes to commercialize next-generation battery solutions.

At the core of Amprius' product portfolio are cylindrical and prismatic cells that employ a proprietary silicon nanowire anode, which supports high charge/discharge rates while maintaining cycle life.

Want to see what other hedge funds are holding AMPX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amprius Technologies, Inc. (NYSE:AMPX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.